BioVie: Developing Breakthrough Therapies for Unmet Medical Needs

1 year ago
9
BioVie Neurodegeneration Liver disease NE3107 Alzheimer's Disease Parkinson's Disease Refractory ascites HRS-AKI Clinical-stage company Therapeutics

BioVie is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. The Company is developing NE3107 for Alzheimer’s (AD) and Parkinson’s (PD) and BIV201 for refractory ascites and HRS-AKI. Visit RedChip.com to learn more.

Transcription:

BioVie is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. The Company is developing NE3107 for Alzheimer’s (AD) and Parkinson’s (PD) and BIV201 for refractory ascites and HRS-AKI. Visit RedChip.com to learn more.

Loading comments...